86 FR 51 pgs. 14767-14768 - Bulk Manufacturer of Controlled Substances Application: Noramco Coventry, LLC.

Type: NOTICEVolume: 86Number: 51Pages: 14767 - 14768
Docket number: [Docket No. DEA-809]
FR document: [FR Doc. 2021-05582 Filed 3-17-21; 8:45 am]
Agency: Justice Department
Sub Agency: Drug Enforcement Administration
Official PDF Version:  PDF Version
Pages: 14767, 14768

[top] page 14767

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[Docket No. DEA-809]

Bulk Manufacturer of Controlled Substances Application: Noramco Coventry, LLC.

AGENCY:

Drug Enforcement Administration, Justice.

ACTION:

Notice of application.

SUMMARY:

Noramco Coventry, LLC. has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplemental Information listed below for further drug information.

DATES:

Registered bulk manufacturers of the affected basic class(es), and applicants therefore, may file written comments on or objections to the issuance of the proposed registration on or before May 17, 2021. Such persons may also file a written request for a hearing on the application on or before May 17, 2021.

ADDRESSES:

Written comments should be sent to: Drug Enforcement Administration, Attention: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, Springfield, Virginia 22152.

SUPPLEMENTARY INFORMATION:

In accordance with 21 CFR 1301.33(a), this is notice that on January 13, 2021, Noramco Coventry, LLC., 498 Washington Street, Coventry, Rhode Island 02816, applied to be registered as a bulk manufacturer of the following basic class(es) of controlled substances:

Controlled substance Drug code Schedule
Marihuana 7360 I
Tetrahydrocannabinols 7370 I
Dihydromorphine 9145 I
Methylphenidate 1724 II
Oxycodone 9143 II
Hydromorphone 9150 II
Hydrocodone 9193 II
Levorphanol 9220 II
Morphine 9300 II
Oripavine 9330 II
Thebaine 9333 II
Oxymorphone 9652 II
Noroxymorphone 9668 II
Tapentadol 9780 II


[top] The company plans to bulk manufacture the listed controlled substances for use as intermediates and converted to other controlled substances or for sale to its customers. In reference to drug codes 7360 (Marihuana), and 7370 (Tetrahydrocannabinols), the company plans to bulk manufacture these drugs as synthetics. No other page 14768 activities for these drug codes are authorized for this registration.

William T. McDermott,

Assistant Administrator.

[FR Doc. 2021-05582 Filed 3-17-21; 8:45 am]

BILLING CODE P